Sunnyvale, CA, United States of America

Gregory W Hemmi

This inventor holds 34 USPTO granted patents, plus 1 CIPO patent, primarily in Texaphyrin Chemistry. Top assignees: The University of Texas System, Pharmacyclics, Inc.. Active years: 1990-2000.


% Patents Active = 100.0


Average Co-Inventor Count = 3.3

ph-index = 20

Forward Citations = 1,575(Granted Patents)


Location History:

  • Austin, TX (US) (1990 - 1999)
  • Sunnyvale, CA (US) (1995 - 2000)

Company Filing History:


Years Active: 1990-2000

Loading Chart...
Loading Chart...
Areas of Expertise:
Texaphyrins
Metal Complexes
Pharmaceutical Compositions
MRI Enhancement
Tumor Treatment
Water Soluble
Radiation Sensitization
Singlet Oxygen
Fluorescence Detection
Expanded Porphyrins
Conjugates
Neoplastic Tissue
34 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gregory W Hemmi

Introduction: Gregory W Hemmi, a talented inventor based in Sunnyvale, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Hemmi's latest patents showcase his expertise in areas such as artificial intelligence, renewable energy, and biotechnology, solidifying his reputation as a forward-thinker in the industry.

Career Highlights: With a career spanning over two decades, Gregory W Hemmi has worked for several renowned tech companies, leading research teams and spearheading projects that have pushed the boundaries of what is possible in the tech world.

Collaborations: Throughout his career, Hemmi has collaborated with top researchers, scientists, and engineers, fostering a culture of innovation and creativity that has resulted in numerous successful projects and patents.

Conclusion: Gregory W Hemmi's passion for innovation and his relentless drive to create a better future through technology make him a true pioneer in the field of inventions. His work continues to inspire and shape the technological landscape for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…